Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just caught something interesting in the biotech space. Firefly Neuroscience stock jumped 80% recently, and honestly, the underlying story is pretty compelling if you're paying attention to where AI is heading.
So here's what happened - they announced they've made serious progress on building what could be the world's first EEG/ERP-based foundation model of the human brain. Not just incremental stuff either. Their commercial footprint expanded over 20x, and they're processing way more brain scans now. After acquiring Evoke Neuroscience, they ended up with 99 commercial partners running over 10,800 EEG/ERP scans. The year-over-year growth numbers are wild - partner sites up 1,880%, clinical assessments up 3,227%.
What caught my eye is the data they've accumulated. They now have more than 191,000 EEG/ERP brain scans in their database, apparently the largest standardized repository in the world. That's the kind of clean data foundation you need to actually train a meaningful foundation model. They're using NVIDIA L40S GPU acceleration to process all this, which makes sense for the computational load.
Their FDA-cleared tech is designed for diagnosing and monitoring stuff like depression, dementia, anxiety, concussions, ADHD. Pretty significant if they can actually pull off building a human brain foundation model that clinicians and researchers can actually use. The CEO mentioned they're positioning this for commercial launch of the foundation model itself.
Stock was trading between $0.62 and $6.00 over the past year, so there's definitely volatility here. Currently at $1.23 after the 80% pop. Whether this becomes a real breakthrough or another biotech hype cycle, hard to say. But the data accumulation and technical progress seem legit. Worth watching if you're interested in where AI-driven diagnostics are heading.